Your browser doesn't support javascript.
loading
Prognostic significance of uncertain resection for metastasis in the highest mediastinal lymph node after surgery for clinical N0 non-small cell lung cancer.
Marziali, Valentina; Frasca, Luca; Ambrogi, Vincenzo; Patirelis, Alexandro; Longo, Filippo; Crucitti, Pierfilippo.
Affiliation
  • Marziali V; Department of Thoracic Surgery, University Tor Vergata, Rome, Italy.
  • Frasca L; Department of Thoracic Surgery, University Campus Bio-Medico, Rome, Italy.
  • Ambrogi V; Microbiology, Immunology, Infectious Diseases, and Transplants (MIMIT), University Tor Vergata, Rome, Italy.
  • Patirelis A; Department of Thoracic Surgery, University Tor Vergata, Rome, Italy.
  • Longo F; Department of Thoracic Surgery, University Tor Vergata, Rome, Italy.
  • Crucitti P; Department of Thoracic Surgery, University Campus Bio-Medico, Rome, Italy.
Front Surg ; 10: 1115696, 2023.
Article in En | MEDLINE | ID: mdl-37396297
ABSTRACT

Background:

The International Association for the Study of Lung Cancer defined types of surgical resection and considered the positivity of the highest mediastinal lymph node resected a parameter of "uncertain resection" (R-u). We investigated the metastases in the highest mediastinal lymph node, defined as the lowest numerically numbered station among those resected. We aimed to evaluate the prognostic value of R-u compared with R0. Materials and

methods:

We selected 550 patients with non-small cell lung cancer at clinical Stage I, IIA, IIB (T3N0M0), or IIIA (T4N0M0) undergoing lobectomy and systematic lymphadenectomy between 2015 and 2020. The R-u group included patients with positive highest mediastinal resected lymph node.

Results:

In the groups of patients with mediastinal lymph node metastasis, we defined 31 as R-u (45.6%, 31/68). The incidence of metastases in the highest lymph node was related to the pN2 subgroups (p < 0.001) and the type of lymphadenectomy performed (p < 0.001). The survival analysis compared R0 and R-u 3-year disease-free survival was 69.0% and 20.0%, respectively, and 3-year overall survival was 78.0% and 40.0%, respectively. The recurrence rate was 29.7% in R0 and 71.0% in R-u (p-value < 0.001), and the mortality rate was 18.9% and 51.6%, respectively (p-value < 0.001). R-u variable showed a tendency to be a significant prognostic factor for disease-free survival and overall survival (hazard ratio 4.6 and 4.5, respectively, p-value < 0.001).

Conclusions:

The presence of metastasis in the highest mediastinal lymph node removed seems to be an independent prognostic factor for mortality and recurrence. The finding of these metastases represents the margin of cancer dissemination at the time of surgery, so it could imply metastasis into the N3 node or distant metastasis.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Surg Year: 2023 Document type: Article Affiliation country: Italia

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Front Surg Year: 2023 Document type: Article Affiliation country: Italia